Physician profile
Amy Benedict
NPI 1760660633
$5,843.63
in general payments reported to CMS, 2019-2025
25 companies · $17.99 in 2025
The $17.99 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $188 · 2023: $4,852 · 2024: $785 · 2025: $17.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,258 · Education: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,257.51 |
| Education | $397.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $968.43 | 2022-2024 | Sotyktu |
| Janssen Biotech, INC. | $863.50 | 2022-2024 | Tremfya, Simponi, Simponi Aria |
| Abbvie INC. | $828.61 | 2023-2024 | |
| Genzyme Corporation | $527.01 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $459.03 | 2022-2024 | |
| Amgen INC. | $353.46 | 2022-2024 | Otezla |
| Sun Pharmaceutical Industries INC. | $331.80 | 2023-2024 | Ilumya, Winlevi, Absorica Ld |
| Incyte Corporation | $213.63 | 2022-2024 | Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $180.46 | 2023-2024 | Siliq, Targretin |
| Ucb, INC. | $177.27 | 2022-2024 | Bimzelx, Cimzia |
| Pfizer INC. | $169.54 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $134.99 | 2023-2024 | Cyltezo, Spevigo |
| Fresenius Kabi USA, LLC | $104.81 | 2023-2024 | Idacio |
| Lilly USA, LLC | $102.31 | 2023-2024 | Taltz, Olumiant |
| Dermavant Sciences, INC. | $98.12 | 2023 | Vtama |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $76.53 | 2023 | Dupixent |
| Arcutis Biotherapeutics, INC. | $53.09 | 2023 | |
| Mylan Institutional INC. | $32.74 | 2023 | Hulio |
| Sandoz INC. | $30.50 | 2023 | Hyrimoz |
| Leo Pharma INC. | $25.91 | 2023 | Adbry |
| Helsinn Therapeutics (U.S.), INC. | $24.78 | 2023 | Valchlor |
| Blueprint Medicines Corporation | $24.18 | 2023 | Ayvakit |
| Organon LLC | $22.16 | 2023 | Hadlima |
| Kyowa Kirin, INC. | $20.74 | 2023 | Poteligeo |
| Biocon Biologics INC | $20.03 | 2024 | Hulio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Benedict listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.